| pubmed-article:11586207 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:11586207 | lifeskim:mentions | umls-concept:C0376358 | lld:lifeskim |
| pubmed-article:11586207 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:11586207 | lifeskim:mentions | umls-concept:C0025663 | lld:lifeskim |
| pubmed-article:11586207 | lifeskim:mentions | umls-concept:C0596790 | lld:lifeskim |
| pubmed-article:11586207 | lifeskim:mentions | umls-concept:C0454527 | lld:lifeskim |
| pubmed-article:11586207 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:11586207 | lifeskim:mentions | umls-concept:C0026051 | lld:lifeskim |
| pubmed-article:11586207 | lifeskim:mentions | umls-concept:C1519043 | lld:lifeskim |
| pubmed-article:11586207 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:11586207 | pubmed:dateCreated | 2001-10-4 | lld:pubmed |
| pubmed-article:11586207 | pubmed:abstractText | Interstitial microwave thermal therapy is experimental treatment for prostate cancer with the goal of curing disease, while causing fewer complications than standard treatment options. We present a method for delivering interstitial microwave thermal therapy using microwave radiating helical antennae inserted percutaneously under transrectal ultrasound guidance. We report the results of a trial of this method in 25 patients in whom primary external beam radiation therapy had previously failed. This patient group currently has limited curative options that are associated with a high complication rate. However, these recurrent tumors often remain localized to the prostate, and so they may be amenable to localized therapy. | lld:pubmed |
| pubmed-article:11586207 | pubmed:language | eng | lld:pubmed |
| pubmed-article:11586207 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:11586207 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:11586207 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:11586207 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:11586207 | pubmed:issn | 0022-5347 | lld:pubmed |
| pubmed-article:11586207 | pubmed:author | pubmed-author:ToiAA | lld:pubmed |
| pubmed-article:11586207 | pubmed:author | pubmed-author:TrachtenbergJ... | lld:pubmed |
| pubmed-article:11586207 | pubmed:author | pubmed-author:DavidsonS RSR | lld:pubmed |
| pubmed-article:11586207 | pubmed:author | pubmed-author:SherarM DMD | lld:pubmed |
| pubmed-article:11586207 | pubmed:author | pubmed-author:YuhC HCH | lld:pubmed |
| pubmed-article:11586207 | pubmed:author | pubmed-author:O'MalleyM EME | lld:pubmed |
| pubmed-article:11586207 | pubmed:author | pubmed-author:GladmanA SAS | lld:pubmed |
| pubmed-article:11586207 | pubmed:author | pubmed-author:GertnerM RMR | lld:pubmed |
| pubmed-article:11586207 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:11586207 | pubmed:volume | 166 | lld:pubmed |
| pubmed-article:11586207 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:11586207 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:11586207 | pubmed:pagination | 1707-14 | lld:pubmed |
| pubmed-article:11586207 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:11586207 | pubmed:meshHeading | pubmed-meshheading:11586207... | lld:pubmed |
| pubmed-article:11586207 | pubmed:meshHeading | pubmed-meshheading:11586207... | lld:pubmed |
| pubmed-article:11586207 | pubmed:meshHeading | pubmed-meshheading:11586207... | lld:pubmed |
| pubmed-article:11586207 | pubmed:meshHeading | pubmed-meshheading:11586207... | lld:pubmed |
| pubmed-article:11586207 | pubmed:meshHeading | pubmed-meshheading:11586207... | lld:pubmed |
| pubmed-article:11586207 | pubmed:meshHeading | pubmed-meshheading:11586207... | lld:pubmed |
| pubmed-article:11586207 | pubmed:meshHeading | pubmed-meshheading:11586207... | lld:pubmed |
| pubmed-article:11586207 | pubmed:meshHeading | pubmed-meshheading:11586207... | lld:pubmed |
| pubmed-article:11586207 | pubmed:year | 2001 | lld:pubmed |
| pubmed-article:11586207 | pubmed:articleTitle | Interstitial microwave thermal therapy for prostate cancer: method of treatment and results of a phase I/II trial. | lld:pubmed |
| pubmed-article:11586207 | pubmed:affiliation | Division of Medical Physics, Ontario Cancer Institute/Princess Margaret Hospital, Ontario, Canada. | lld:pubmed |
| pubmed-article:11586207 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:11586207 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:11586207 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:11586207 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
| pubmed-article:11586207 | pubmed:publicationType | Clinical Trial, Phase I | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:11586207 | lld:pubmed |
